H.R. 2391 - Medicaid Generic Drug Price Fairness Act of 2015
- Sponsor:
- Elijah E. Cummings
- Summary:
- To amend title XIX of the Social Security Act to require the payment of an additional rebate to the State Medicaid plan in the case of increase in the price of a generic drug at a rate that is greater than the rate of inflation. (by CRS)
- Status:
- The bill has been referred to committee.
Medicaid Generic Drug Price Fairness Act of 2015
H.R. 2391 — 114th Congress (2015–2016)
- Summary
- To amend title XIX of the Social Security Act to require the payment of an additional rebate to the State Medicaid plan in the case of increase in the price of a generic drug at a rate that is greater than the rate of inflation. (by CRS)
- Learn More
- At OpenCongress
- Title
- To amend title XIX of the Social Security Act to require the payment of an additional rebate to the State Medicaid plan in the case of increase in the price of a generic drug at a rate that is greater than the rate of inflation.
- Other Titles
- Medicaid Generic Drug Price Fairness Act of 2015
- Medicaid Generic Drug Price Fairness Act of 2015
- Sponsor
- Elijah E. Cummings
- Co-Sponsors
- Subjects
- Health
- Medicaid
- Prescription drugs
- Related Bills
- Major Actions
Introduced 5/18/2015 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 5/18/2015 5/18/2015 Referred to the House Committee on Energy and Commerce. 5/18/2015 Introduced in House 5/22/2015 Referred to the Subcommittee on Health. Number Sponsor Date Offered Status
MapLight did not identify any interest groups that took a position on this vote.
You may be able to explore campaign contributions data if you add interest groups.
Contributions data source: OpenSecrets.org